KitoTech Medical Introduces microMend® UMBILICAL Device for Closing the Umbilical Port Site in Laparoscopic and Robotic Surgeries

​Seattle, WA (July 28, 2021) - KitoTech Medical, manufacturer of microMend® wound closure devices, announces the launch of microMend UMBILICAL, the newest addition to our growing family of wound closure products. The product was specifically designed to close port site wounds associated with minimally invasive surgeries including laparoscopic and robotic surgeries. During these surgeries, several instruments are inserted through the skin to perform surgical procedures. These leave four to five skin wounds known as port sites which need to be closed. One of the common port sites is the umbilicus which is challenging to close due to its irregular and often concave skin surface. The microMend UMBILICAL device is specifically designed to close this site and can be used by surgeons in conjunction with other microMend devices to close the other port sites.

microMend UMBILICAL demonstrates a commitment to design products to close specific types of wounds in the body and expands the use of microMend products. It opens up a significant market for KitoTech given that there are over five million minimally invasive surgeries performed annually in the US. 

 “The UMBILICAL device represents another example of the innovative microMend products that KitoTech is developing to address the many and varied needs of closing wounds for surgeons,” stated Ron Berenson, President and CEO.  “The device makes it convenient to close the umbilical port site with the ease and speed of our other microMend products. With this device, we now have a total microMend solution for closing nearly all port sites encountered during minimally invasive surgeries. We look forward to working with surgeons to make microMend a new standard for port site skin closure.”

---